News

From January 2026, inmedis GmbH and Imfeld Unternehmensberatung GmbH will combine their strengths to offer customers an expanded range of services and even more expertise from a single source. The projects of Imfeld Unternehmensberatung's will continue under the joint umbrella of inmedis GmbH. During the year 2026, we plan to convert into a public limited company. Our values and goals remain unchanged. We continue to offer security in medtech - effective, pragmatic and collaborative. 

We share an important inmedis working tool with you: our list of providers of digital QMS solutions for medical technology.

We are happy to make this treasure of knowledge available to you, combined with the hope that you share your feedback and experience with us:

• Which QMS tools do you use?
• What are your experiences with them?
• Which e-QMS providers for MedTech are missing on the list?

All information is taken from websites or sales materials of the providers and does not include any evaluation of customer satisfaction, usability or costs. Please send feedback to digital@inmedis.ch. We will publish the results collected.

With the amendment of Regulation 2017/745 of the European Parliament and of the Council of 15 March 2023, longer transition periods apply to legacy devices. We have prepared a clear overview of the transition periods for you according to medical device classes, including the EUDAMED roadmap updated in October. See the result of our analysis in the following documents.

Contact us if you have any questions regarding MDR, MepV & Co.